Using HPV prevalence to predict cervical cancer incidence

International Journal of Cancer

Volumn 132, Issue 8, 2013, Pages 1895-1900

  Sharma, Monisha ^a   Bruni, Laia ^b   Diaz, Mireia ^b   Castellsagué, Xavier ^b,c   Sanjosé, Silvia De ^b,c   Bosch, F Xavier ^b   Kim, Jane J ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^c CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

Author keywords

cervical cancer; human papilloma virus; prediction modeling

Indexed keywords

ADULT; AFRICA SOUTH OF THE SAHARA; ARTICLE; ASIA; CANCER INCIDENCE; CANCER REGISTRY; CANCER RISK; CENTRAL AMERICA; CONDYLOMA; CONTROLLED STUDY; DISEASE ASSOCIATION; EASTERN EUROPE; EDUCATIONAL STATUS; FEMALE; GROSS NATIONAL PRODUCT; GROUPS BY AGE; HEALTH PRACTITIONER; HUMAN; LIFE EXPECTANCY; MATERNAL MORTALITY; MEASLES VACCINATION; NEWBORN MORTALITY; NORTH AFRICA; PHYSICIAN; PREDICTION; PREDICTIVE VALIDITY; PREVALENCE; PRIORITY JOURNAL; RELIGION; SCREENING; SOCIOECONOMICS; SOUTH AMERICA; TUBERCULOSIS; UTERINE CERVIX CANCER; WART VIRUS;

ADULT; ALPHAPAPILLOMAVIRUS; FEMALE; HUMANS; INCIDENCE; MIDDLE AGED; PREVALENCE; UTERINE CERVICAL NEOPLASMS;

EID: 84873999505     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.27835     Document Type: Article

References (25)

1. Globocan Cancer Fact Sheet: 2008. Accessed on 8/17/2011 from: http://globocan.iarc.fr/factsheets/cancers/cervix.asp.
2. Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; 127: 2893-917.
3. Cancer Registration: Principles and Methods, IARC and WHO. Accessed 20 July 2011. http://www.iarc.fr/en/publications/pdfs-online/ epi/.
4. Parkin DM,. The evolution of the population-based cancer registry. Nat Rev Cancer 2006; 6: 603-12.
5. Parkin DM, Bray F,. The burden of HPV-related cancers. Vaccine 2006; 24 (Suppl 3): S11-25.
6. Bruni L, Diaz M, Castellsague X, et al. Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. J Infect Dis 2010; 202: 1789-99.
7. WHO Statistical Information System. Accessed 12 February 2012. http://www.who.int/whosis/indicators/compendium/2008/1mst/en/index.html.
8. IARC: Cancer Incidence in 5 Continents. Accessed on 16 March 2010. http://ci5.iarc.fr/CI5i-ix/ci5i-ix.htm.
9. Globocan 2008. Accessed 16 March 2010. http://globocan.iarc.fr/.
10. United Nations Statistics Division. Accessed 21 August 2011. http://unstats.un.org/unsd/methods/m49/m49regin.htm.
11. WHO/ICO HPV Information Centre. Accessed 28 September 2011. http://www.who.int/hpvcentre/statistics/en/.
12. UNDP World Development Indicators. Accessed 15 February 2010. http://hdr.undp.org/en/media/HDR-20072008-EN-Indicator-tables.pdf.
13. The World Health Report 2006. Accessed 10 February 2011. http://www.who.int/whr/2006/whr06-en.pdf.
14. World Bank Development Indicators. Accessed 21 August 2011. http://data.worldbank.org/indicator/all.
15. WHO World Health Statistics. Accessed 15 February 2011. http://apps.who.int/globalatlas/dataQuery/default.asp.
16. UNICEF's State of the World's Children. Accessed 15 February 2011. http://www.unicef.org/sowc/.
17. CIA World Factbook 2011. Accessed 25 August 2011. https://www.cia.gov/ library/publications/the-world-factbook/.
18. StataCorp. 2005. Stata Statistical Software: Release 9. College Station, TX: StataCorp LP.
19. Stata Web Books: Regression with Stata. Accessed 4 December 2011. http://www.ats.ucla.edu/stat/stata/webbooks/reg/chapter2/statareg2.htm.
20. Maucort-Boulch D, Franceschi S, Plummer M,. International correlation between human papillomavirus prevalence and cervical cancer incidence. Cancer Epidemiol Biomarkers Prev 2008; 17: 717-20.
21. Chen HC, Schiffman M, Lin CY, et al. Persistence of type-specific human papillomavirus infection and increased long-term risk of cervical cancer. J Natl Cancer Inst 2011; 103: 1387-96.
22. Castle PE, Rodriguez AC, Burk RD,. Short term persistence of human papillomavirus and risk of cervical precancer and cancer: population based cohort study. BMJ 2009; 339: b2569.
23. Kjaer SK, Frederiksen K, Munk C, et al. Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence. J Natl Cancer Inst 2010; 102: 1478-88.
24. Drain PK, Holmes KK, Hughes JP, et al. Determinants of cervical cancer rates in developing countries. Int J Cancer 2002; 100: 199-205.
25. Shi JF, Qiao YL, Smith JS, et al. Epidemiology and prevention of human papillomavirus and cervical cancer in China and Mongolia. Vaccine 2008; 26 (Suppl 12): M53-9.